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Introduction
Many compounds classified as human carcinogens are known to form DNA adducts in vivo (1) . Impetus to apply DNA adduct formation as a biomarker of human cancer risk comes from extensive studies in animal models in which DNA adduct formation has been shown to be necessary but not sufficient for tumorigenesis. Estimation 
Methodological Approaches to Human DNA Adduct Monitoring
Single methods currently in use for carcinogen-DNA adduct detection include immunoassays (6), immunohistochemistry (7,8), 32P-postlabeling (9, 10) , fluorescence and phosphorescence spectroscopy (11), gas chromatography-mass spectrometry (GC-MS) (12), atomic absorbance spectrometry (13, 14) , and electrochemical conductance (ECC) (15) . These methods, applied individually, are typically not able to chemically characterize specific adducts. Therefore, an important aspect of more recent approaches to human biomonitoring is the development of preparative strategies for sample purification that can be applied prior to the ultimate adduct quantitation (16) . Recent advances combining preparative chromatography with immunoassays, 32P-postlabeling, synchronous fluorescence spectrometry (SFS), and GC-MS have allowed identification and quantitation of specific DNA adducts in human tissues, thereby strengthening human exposure documentation. The two most frequently employed DNA adduct methodologies, immunoassays and 32P-postlabeling, will be discussed briefly. Antisera elicited against DNA adducts and carcinogen-modified DNA samples (17) (18) (19) have been widely utilized to quantify and localize xenobiotic-induced DNA damage (20) (21) (22) (23) and to measure DNA adduct formation in human tissues (24, 25 (70, 71) and PAHs (72, 73) , while GC-MS is routinely applied for 4-aminobiphenyl (74) , N-nitrosamines (12, (75) (76) (77) (78) , and tobacco-specific nitrosamines (79) . Atomic absorbance spectrometry is used for cisplatin (80, 81) and electrochemical detection is used for oxidative DNA damage (82, 83 dosimetry of aflatoxin exposure, 42 individuals in the Guanxi region of China (89) were studied. A portion of the actual food consumed was assayed for aflatoxin content and urinary output was assayed for excretion of aflatoxin B1-N7-guanine by both males and females (37, 90) . The dosimetry data showed an excellent correlation between dietary aflatoxin intake and urinary adduct excretion (91 
